Long‐Term survival of patients treated with photodynamic therapy for carcinoma in situ and early non‐small‐cell lung carcinoma

Abstract

PDT is effective in early primary or recurrent NSCLC, resulting in a CR rate of 72%. The incorporation of PDT in standard clinical practice, in combination with radiotherapy, warrants further investigation.